Dr. Maryana Shenderov is a clinician at the Johns Hopkins University School of Medicine, having joined in 2016. Her area of clinical expertise is infectious disease. She earned her M.D. from SUNY Downstate Medical Center. She completed her residency and a fellowship in infectious diseases at the University of Maryland Medical Center. Dr. Maryana Shenderov sees patients at the Greenspring Station and Bartlett Infectious Diseases Clinics and also provides inpatient consultations at Johns Hopkins Hospital. She is committed to excellence in patient care, multi-disciplinary collaboration, and patient-centered care. Dr. Shenderov is rated as a Distinguished provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Osteomyelitis, Osteomyelitis in Children, SAPHO Syndrome, and Chronic Recurrent Multifocal Osteomyelitis.

Dr. Abularrage specializes in vascular and endovascular surgery, with a specific interest in minimally invasive techniques for lower extremity peripheral arterial disease and aneurysm repair. His clinical interests include limb preservation, Diabetic peripheral arterial disease and limb salvage, aortic aneurysms, endovascular aneurysm repair, visceral stents and bypass, and carotid stents and carotid endarterectomy. Dr. Abularrage is an active researcher within the department and has published widely on outcomes research using large, national databases. Recently, Dr. Abularrage and his team have published their outcomes of patients treated in the Multidisciplinary Diabetic Foot & Wound Clinic, showing significantly lower amputation rates compared to national benchmarks. Dr. Abularrage is a distinguished fellow to the Society of the American Board of Surgery, and recipient of the Zehner Award and the R. Clement Darling, Jr. Award. He is nationally renowned for his work in Diabetic peripheral arterial disease and limb preservation. Dr. Abularrage is rated as a Distinguished provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Peripheral Artery Disease, Carotid Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as a Distinguished provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

William F. Wright, D.O., M.P.H, Assistant Professor of Medicine, completed medical training residency in internal medicine and adult infectious diseases fellowship at Pennylvania State University Medical School. He pursued further training in Clinical Pathology/Medical Microbiology at Yale University School of Medicine, New Haven (2009) and completed his Master in Public Health (2007) at Drexel University School of Public Health, Philadelphia. His research interests include fever of unknown origin (FUO), antimicrobial resistance and therapeutic discoveries, molecular mechanisms of resistance, and the impact of diagnostic clinical microbiology on the practice of infectious diseases. He currently serves as clinical director for the inpatient infectious diseases consult services and services for the management of outpatient parenteral antimicrobial therapy (OPAT) at Johns Hopkins Bayview Medical Center. His outpatient clinical practice focuses on general infectious diseases, infections in burn patients, infections in immunocompromised patients, and travel-related infections. He primarily sees patients at Johns Hopkins Greenspring Station, Johns Hopkins Bayview Outpatient offices, and also attends on the inpatient infectious disease consult service at the Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Meningitis, and Endocarditis.

Chandralekha Banerjee is an Infectious Disease provider in Baltimore, Maryland. Dr. Banerjee is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, HIV/AIDS, and AIDS Dementia Complex. Dr. Banerjee is currently accepting new patients.

Dilraj Deol is an Infectious Disease provider in Baltimore, Maryland. Dr. Deol is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Cellulitis, Infective Endocarditis, Myelitis, and AIDS Dementia Complex. Dr. Deol is currently accepting new patients.

Michelle Bahrain is an Infectious Disease provider in Baltimore, Maryland. Dr. Bahrain is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Sepsis, Osteomyelitis, Infectious Arthritis, and Spontaneous Bacterial Peritonitis. Dr. Bahrain is currently accepting new patients.

Theodore Bailey is an Infectious Disease provider in Baltimore, Maryland. Dr. Bailey is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Sepsis, Osteomyelitis, SAPHO Syndrome, and Osteomyelitis in Children. Dr. Bailey is currently accepting new patients.

Dr. Susan Tuddenham is an associate professor of medicine at the Johns Hopkins University School of Medicine. She received her M.P.H. from the Johns Hopkins Bloomberg School of Public Health and her M.D. from the David Geffen School of Medicine at UCLA. She completed her residency in internal medicine and her fellowship in infectious diseases at the Johns Hopkins Hospital. Her research interests are in sexually transmitted infections, HIV, and the human microbiome in the context of infectious diseases. Her outpatient clinical practice focuses on recurrent vaginitis (including Bacterial Vaginosis and Vulvovaginal Candidiasis), Sexually Transmitted Infections, and recurrent Urinary Tract Infections in women. Dr. Tuddenham is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Neurosyphilis, Syphilis, Gonorrhea, and Vaginal Yeast Infection.

Dr. Bradley C. Strunk is an instructor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Strunk is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Strunk earned his M.D. at Johns Hopkins. He completed his residency at Johns Hopkins Bayview Medical Center. Dr. Strunk is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Sickle Cell Disease, Renovascular Hypertension, Necrosis, Endoscopy, and Ureteroscopy.

Dr. Poonum S. Korpe is a faculty member at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Her area of clinical expertise is infectious diseases. Dr. Korpe earned her M.D. at Eastern Virginia Medical School. She completed her residency and performed a fellowship in infectious diseases at University of Virginia Health System. She is currently investigating the natural history of cryptosporidiosis in Bangladeshi children as a way to better understand human immune responses to the infection. Dr. Korpe is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Shigellosis, Osteomyelitis, Amebiasis, and Viral Gastroenteritis.

Morgan Katz, M.D., MHS, is an Associate Professor of medicine at The Johns Hopkins University School of Medicine and the Director of Antimicrobial Stewardship at Johns Hopkins Bayview Hospital. Her area of clinical expertise is infectious diseases. Her research interests lie in infection control and antibiotic stewardship in long-term care facilities. She has focused her career on designing feasible interventions to reduce antimicrobial resistance and transmission of infection in the long-term care setting. She served as a member of the White House Nursing Home Commission to guide the Centers for Medicare and Medicaid in their response to Coronavirus in long-term care facilities, and has published widely on infection prevention and antibiotic stewardship in long-term care. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Lemierre Syndrome, Severe Acute Respiratory Syndrome (SARS), COVID-19, Osteomyelitis, and Thrombectomy.

Tara Hebert, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in internal medicine at Johns Hopkins Medicine School of Medicine. Dr. Hebert is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Matthew Robinson, MD, is Assistant Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. He is interested in leveraging diagnostic innovation and precision medicine to reduce diagnostic and prognostic uncertainty for infectious diseases. His current projects include applications in global health, antimicrobial resistance, antibiotic stewardship, infection control, COVID-19, acute febrile illness, and tuberculosis. After undergraduate and medical school at Northwestern University, he completed internal medicine residency at New York University and Infectious Diseases fellowship at Johns Hopkins School of Medicine. During medical school, he worked at the Chinese Center for Disease Control and Prevention in Beijing, China under a Doris Duke International Clinical Research Fellowship. He also served as a clinician educator in internal medicine in Gulu, Uganda at the Gulu University Faculty of Medicine as a Global Health Service Partnership volunteer. As a fellow, he pursued a Fogarty Global Health Fellowship in Pune, India and an Antibacterial Resistance Leadership Group Fellowship. Since joining the faculty in 2019, Dr. Robinson has been supported by the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration. The focus of his work in antimicrobial resistance, antibiotic stewardship, infection control has been to characterize drug-resistant Gram-negative infections in India. His work with the Johns Hopkins Precision Medicine Center of Excellence for COVID-19 has included applying machine learning and causal inference techniques to predict COVID-19 outcomes. He has contributed to SARS-CoV-2 diagnostic development through the NIH Rapid Acceleration of Diagnostics (RADx) initiative and through collaborative development of other novel diagnostics. Dr. Robinson is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Togaviridae Disease, and Dengue Fever.

Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine. Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa). Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis. Dr. Lippincott is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, Osteomyelitis, and Osteomyelitis in Children.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Dr. Michael T. Melia is an Associate Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general infectious diseases, HIV and Lyme disease. He serves as the Director of the Infectious Diseases Fellowship Program. After receiving his medical degree from the Georgetown University School of Medicine, Dr. Melia completed his internal medicine residency, infectious diseases fellowship, and chief medical residency at the Beth Israel Deaconess Medical Center. He joined the Johns Hopkins faculty in 2008. Dr. Melia's academic and research interests center around medical education and coaching in medicine. He is the current Chair of the IDSA Medical Education Community of Practice and is a past Chair of the IDSA Training Program Directors' Committee. In 2015, Dr. Melia was recognized with the Outstanding Achievement in Teaching Award from the Institute for Excellence in Education at the Johns Hopkins University School of Medicine. Dr. Melia is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Lyme Disease, Hepatitis C, Allergic Bronchopulmonary Aspergillosis, and HIV/AIDS.